![David Arkowitz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Arkowitz
Director/Board Member at
IBIO, INC.
Net worth: 34 926 $ as of 2026-05-30
Profile
David A. Arkowitz is currently Director at Yumanity, Inc., Independent Director at iBio, Inc. since 2024, and Chief Financial Officer at Alkeus Pharmaceuticals, Inc. since 2024.
Former positions include Director at ImpactRx, Inc. (2009), Director at Aegerion Pharmaceuticals, Inc. (2009), Director-Financial Planning & Analysis at Merck-Medco Managed Care LLC, Independent Director at Proteostasis Therapeutics, Inc., Independent Director at F-Star Therapeutics, Inc. (2020–2023), Independent Director at Kineta, Inc. (2022–2025), Independent Director at Yumanity Therapeutics, Inc. (2020–2022), VP & Controller-Research & Development Division at Merck & Co., Inc. (2003), Chief Financial Officer & Treasurer at Idenix Pharmaceuticals LLC (2003–2007), Chief Financial Officer & General Manager at Mascoma Corp.
(2011–2013), Chief Financial & Accounting Officer at Flexion Therapeutics, Inc. (2018–2021), Vice President-Finance & Business Development at Merck Frosst Canada Ltd. (2000),.
Controller at Merck Research Laboratories Massachusetts LLC (1990–2003), Chief Financial & Business Officer at AMAG Pharmaceuticals, Inc. (2007–2011), CFO, Executive VP & Head-Business Development at Seres Therapeutics, Inc. (2021–2024), and Chief Operating & Financial Officer at Visterra, Inc. (2013–2018).
Education includes undergraduate studies at Brandeis University and an MBA from Columbia Business School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
IBIO, INC. 0.05% | 2025-11-19 | 18,382 ( 0.05% ) | 34 926 $ | 2026-05-30 |
David Arkowitz active positions
| Companies | Position | Start |
|---|---|---|
| IBIO, INC. | Director/Board Member | 2024-11-24 |
Alkeus Pharmaceuticals, Inc.
 Alkeus Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Provides degenerative retinal diseases treatment services | Director of Finance/CFO | 2024-09-30 |
Yumanity, Inc.
 Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Provides transforming drug discovery for neurodegenerative diseases services | Director/Board Member | - |
Former positions of David Arkowitz
| Companies | Position | End |
|---|---|---|
| KINETA, INC. | Director/Board Member | 2025-06-29 |
| SERES THERAPEUTICS, INC. | Director of Finance/CFO | 2024-03-14 |
| F-STAR THERAPEUTICS, INC. | Director/Board Member | 2023-03-07 |
| YUMANITY THERAPEUTICS | Director/Board Member | 2022-11-30 |
| FLEXION THERAPEUTICS, INC. | Director of Finance/CFO | 2021-05-30 |
Training of David Arkowitz
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
74
1st degree connections
22
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 22 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Idenix Pharmaceuticals LLC
 Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of human viral and infectious diseases caused by hepatitis | Health Technology |
ImpactRx, Inc.
 ImpactRx, Inc. Miscellaneous Commercial ServicesCommercial Services Provides health-care sector custom research and promotional consultancy services | Commercial Services |
Aegerion Pharmaceuticals, Inc.
 Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for hyperlipidemia and metabolic diseases | Health Technology |
Mascoma Corp.
 Mascoma Corp. BiotechnologyHealth Technology Develops technology for abundant biomass conversion | Health Technology |
Flexion Therapeutics, Inc.
 Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of patients with musculoskeletal conditions | Health Technology |
Visterra, Inc.
 Visterra, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Merck-Medco Managed Care LLC
 Merck-Medco Managed Care LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
Brandeis University
 Brandeis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck Frosst Canada Ltd.
 Merck Frosst Canada Ltd. Pharmaceuticals: MajorHealth Technology Produces pharmaceutical preparations | Health Technology |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Proteostasis Therapeutics, Inc.
 Proteostasis Therapeutics, Inc. BiotechnologyHealth Technology Develops disease-modifying therapeutics for orphan and neurodegenerative diseases | Health Technology |
iBio, Inc.
 iBio, Inc. Pharmaceuticals: OtherHealth Technology Engages in the development and commercialization of vaccines and therapeutic proteins | Health Technology |
F-Star Therapeutics, Inc. (United States)
 F-Star Therapeutics, Inc. (United States) Pharmaceuticals: MajorHealth Technology Engages in discovery, development and preparation of bioavailable therapeutics | Health Technology |
Alkeus Pharmaceuticals, Inc.
Alkeus Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Provides degenerative retinal diseases treatment services | Health Services |
Seres Therapeutics, Inc.
 Seres Therapeutics, Inc. BiotechnologyHealth Technology Develops novel treatments for diseases related to the human microbiome | Health Technology |
Columbia Business School
 Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yumanity, Inc.
Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Provides transforming drug discovery for neurodegenerative diseases services | Health Technology |
F-star Therapeutics, Inc.
 F-star Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops antibody therapeutics for cancer and other diseases | Health Technology |
Yumanity Therapeutics, Inc.
 Yumanity Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Kineta, Inc.
 Kineta, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
- Stock Market
- Insiders
- David Arkowitz
